Inhibitory effect of epigallocatechin gallate on the virulence of clostridium difficile pcr ribotype 027

Journal of Food Science

Volumn 80, Issue 12, 2015, Pages M2925-M2931

  Yun, Bohyun ^a   Oh, Seunghan ^a   Song, Minyu ^a   Hong, Young Shick ^a   Park, Sungsu ^b   Park, Dong June ^c   Griffiths, Mansel W ^d   Oh, Sejong ^a,d  

^a Chonnam National University   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c Food Research Inst   (South Korea)

^d UNIVERSITY OF GUELPH   (Canada)

Author keywords

Autoinducer 2; Clostridium difficile infection model; Clostridium difficile PCR ribotype 027; Epigallocatechin gallate; Quorum sensing

Indexed keywords

ANTIINFECTIVE AGENT; CATECHIN; EPIGALLOCATECHIN GALLATE; HOMOSERINE; LACTONE; N-OCTANOYLHOMOSERINE LACTONE; PLANT EXTRACT;

ANALOGS AND DERIVATIVES; ANIMAL; BACTERIAL GENE; CAENORHABDITIS ELEGANS; CAMELLIA SINENSIS; CHEMISTRY; CLOSTRIDIUM INFECTIONS; DRUG EFFECTS; GENE EXPRESSION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIOLOGY; MOUSE; PATHOGENICITY; PATHOLOGY; PEPTOCLOSTRIDIUM DIFFICILE; PHYTOTHERAPY; POLYMERASE CHAIN REACTION; QUORUM SENSING; RIBOTYPING; SPECIES DIFFERENCE; VIRULENCE;

ANIMALS; ANTI-BACTERIAL AGENTS; CAENORHABDITIS ELEGANS; CAMELLIA SINENSIS; CATECHIN; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; GENE EXPRESSION; GENES, BACTERIAL; HOMOSERINE; LACTONES; MICE; PHYTOTHERAPY; PLANT EXTRACTS; POLYMERASE CHAIN REACTION; QUORUM SENSING; RIBOTYPING; SPECIES SPECIFICITY; VIRULENCE;

EID: 84979214064     PISSN: 00221147     EISSN: 17503841     Source Type: Journal    
DOI: 10.1111/1750-3841.13145     Document Type: Article

References (45)

1. Ahn YJ, Kawamura T, Kim M, Yamamoto T, Mitsuoka T. 1991. Tea polyphenols: selective growth inhibitors of Clostridium spp. Agric Biol Chem 55:1425–6.
2. Alegado RA, Campbell MC, Chen WC, Slutz SS, Tan MW. 2003. Characterization of mediators of microbial virulence and innate immunity using the Caenorhabditis elegans host–pathogen model. Cell Microbiol 5:435–44.
3. Ballestriero F, Thomas T, Burke C, Egan S, Kjelleberg S. 2010. Identification of compounds with bioactivity against the nematode Caenorhabditis elegans by a screen based on the functional genomics of the marine bacterium Pseudoalteromonas tunicata D2. Appl Environ Microbiol 76:5710–7.
4. Brenner S. 1974. The genetics of Caenorhabditis elegans. Genetics 77:71–94.
5. Carter GP, Purdy D, Williams P, Minton NP. 2005. Quorum sensing in Clostridium difficile: analysis of a luxS-type signalling system. J Med Microbiol 54:119–27.
6. Chao J, Lau WK-W, Huie MJ, Ho Y-S, Yu M-S, Lai CS-W, Wang M, Yuen W-H, Lam WH, Chan TH. 2010. A pro-drug of the green tea polyphenol (−)-epigallocatechin-3-gallate (EGCG) prevents differentiated SH-SY5Y cells from toxicity induced by 6-hydroxydopamine. Neurosci Lett 469:360–4.
7. Chen D, Wan SB, Yang H, Yuan J, Chan TH, Dou QP. 2011. EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment. Adv Clin Chem 53:155–77.
8. Chen X, Katchar K, Goldsmith J, Nanthakumar N, Cheknis A, Gerding D, Kelly C. 2008. A mouse model of Clostridium difficile-associated disease. Gastroenterol 135:1984–92.
9. Cui Y, Kim SH, Kim H, Yeom J, Ko K, Park W, Park S. 2012. AFM probing the mechanism of synergistic effects of the green tea polyphenol (−)-epigallocatechin-3-gallate (EGCG) with cefotaxime against extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli. PloS One 7:e48880.
10. Deka A, Vita JA. 2011. Tea and cardiovascular disease. Pharmacol Res 64:136–45.
11. De Keersmaecker SC, Sonck K, Vanderleyden J. 2006. Let LuxS speak up in AI-2 signaling. Trends Microbiol 14:114–9.
12. Geric B, Carman RJ, Rupnik M, Genheimer CW, Sambol SP, Lyerly DM, Gerding DN, Johnson S. 2006. Binary toxin–producing, large clostridial toxin–negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters. J Infect Dis 193:1143–50.
13. Hara-Kudo Y, Yamasaki A, Sasaki M, Okubo T, Minai Y, Haga M, Kondo K, Sugita-Konishi Y. 2005. Antibacterial action on pathogenic bacterial spore by green tea catechins. J Sci Food Agr 85:2354–61.
14. Hermann C. 2007. Review: variability of host–pathogen interaction. J Endotoxin Res 13:199– 218.
15. Huber B, Eberl L, Feucht W, Polster J. 2003. Influence of polyphenols on bacterial biofilm formation and quorum-sensing. Z Naturforsch 58:879–84.
16. Ikigai H, Nakae T, Hara Y, Shimamura T. 1993. Bactericidal catechins damage the lipid bilayer. Biochim Biophys Acta Rev Biomembr 1147:132–6.
17. Jarchum I, Liu M, Lipuma L, Pamer EG. 2011. Toll-like receptor 5 stimulation protects mice from acute Clostridium difficile colitis. Infect Immun 79:1498–503.
18. Kaper JB, Sperandio V. 2005. Bacterial cell-to-cell signaling in the gastrointestinal tract. Infect Immun 73:3197–209.
19. Kelly CP, LaMont JT. 1998. Clostridium difficile infection. Annu Rev Med 49:375–90.
20. Kociolek MG. 2009. Quorum-sensing inhibitors and biofilms. Anti-Infect Agents Med Chem 8:315–26.
21. Lee ASY, Song KP. 2005. LuxS/autoinducer-2 quorum sensing molecule regulates transcriptional virulence gene expression in Clostridium difficile. Biochem Biophys Res Commun 335:659–66.
22. Lee K-M, Kim W-S, Lim J, Nam S, Youn M, Nam S-W, Kim Y, Kim S-H, Park W, Park S. 2009. Antipathogenic properties of green tea polyphenol epigallocatechin gallate at concentrations below the MIC against enterohemorrhagic Escherichia coli O157: H7. J Food Prot 72:325–31.
23. Maeyama R, Kwon IK, Mizunoe Y, Anderson JM, Tanaka M, Matsuda T. 2005. Novel bactericidal surface: Catechin-loaded surface-erodible polymer prevents biofilm formation. J Biomed Mater Res A 75:146–55.
24. Mani N, Dupuy B. 2001. Regulation of toxin synthesis in Clostridium difficile by an alternative RNA polymerase sigma factor. Proc Natl Acad Sci USA 98:5844–9.
25. Matamouros S, England P, Dupuy B. 2007. Clostridium difficile toxin expression is inhibited by the novel regulator TcdC. Mol Microbiol 64:1274–88.
26. McDonald LC, Killgore GE, Thompson A, Owens Jr RC, Kazakova SV, Sambol SP, Johnson S, Gerding DN. 2005. An epidemic, toxin gene–variant strain of Clostridium difficile. New Engl J Med 353:2433–41.
27. Meijler MM, Hom LG, Kaufmann GF, McKenzie KM, Sun C, Moss JA, Matsushita M, Janda KD. 2004. Synthesis and biological validation of a ubiquitous quorum-sensing molecule. Angew Chem Int Edit 43:2106–8.
28. Nicholas HR, Hodgkin J. 2004. Responses to infection and possible recognition strategies in the innate immune system of Caenorhabditis elegans. Mol immunol 41:479–93.
29. Ohtani K, Hayashi H, Shimizu T. 2002. The luxS gene is involved in cell–cell signalling for toxin production in Clostridium perfringens. Mol microbiol 44:171–9.
30. Reeves AE, Theriot CM, Bergin IL, Huffnagle GB, Schloss PD, Young VB. 2011. The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile Infection. Gut Microbes 2:145–58.
31. Ren D, Bedzyk LA, Ye RW, Thomas SM, Wood TK. 2004. Differential gene expression shows natural brominated furanones interfere with the autoinducer-2 bacterial signaling system of Escherichia coli. Biotechnol Bioeng 88:630–42.
32. Rodriguez-Palacios A, Reid-Smith RJ, Staempfli HR, Daignault D, Janecko N, Avery BP, Martin H, Thomspon AD, McDonald LC, Limbago B, Weese JS. 2009. Possible seasonality of Clostridium difficile in retail meat, Canada. Emerg infect dis 15:802–5.
33. Rupnik M, Songer JG. 2010. Clostridium difficile: Its potential as a source of foodborne disease. Adv Food Nutr Res 60:53–66.
34. SAS User’s Guide: Statistics, Version 6, 12 ed. Cary, NC: SAS Institute
35. Sifri CD, Begun J, Ausubel FM. 2005. The worm has turned: microbial virulence modeled in Caenorhabditis elegans. Trends Microbiol 13:119–27.
36. Songer JG, Trinh HT, Killgore GE, Thompson AD, McDonald LC, Limbago BM. 2009. Clostridium difficile in retail meat products, USA, 2007. Emerg Infect Dis 15:819–21.
37. Spencer RC. 1998. Clinical impact and associated costs of Clostridium difficile-associated disease. J Antimicrob Chemother 41:5–12.
38. Surette MG, Bassler BL. 1998. Quorum sensing in Escherichia coli and Salmonella typhimurium. Proc Natl Acad Sci USA 95:7046–50.
39. Vedantam G, Clark A, Chu M, McQuade R, Mallozzi M, Viswanathan VK. 2012. Clostridium difficile infection: Toxins and non-toxin virulence factors, and their contributions to disease establishment and host response. Gut Microbes 3:121–34.
40. Von Abercron SM, Karlsson F, Wigh GT, Wierup M, Krovacek K. 2009. Low occurrence of Clostridium difficile in retail ground meat in Sweden. J Food Prot 72:1732–4.
41. Weese JS, Avery BP, Rousseau J, Reid-Smith RJ. 2009. Detection and enumeration of Clostridium difficile spores in retail beef and pork. Appl Environ Microbiol 75:5009–11.
42. White R, Chiba S, Pang T, Dewey JS, Savva CG, Holzenburg A, Pogliano K, Young R. 2011. Holin triggering in real time. Proc Natl Acad Sci USA 108:798–803.
43. Yoda Y, Hu ZQ, Zhao WH, Shimamura T. 2004. Different susceptibilities of Staphylococcus and Gram-negative rods to epigallocatechin gallate. J Infect Chemother 10:55–8.
44. Yun B, Oh S, Griffiths M. 2014a. Lactobacillus acidophilus modulates the virulence of Clostridium difficile. J Dairy Sci 97:4745–58.
45. Yun HS, Kim Y, Park MR, Kim SH, Oh S. 2014b. Inhibitory effects of the κ-casein macropep-tide isolated from milk protein on the biofilm formation and virulence of Listeria monocytogenes. Biosci Biotechnol Biochem 78:490–8.